Navigation Links
Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
Date:2/19/2013

TOKYO, Japan (PRWEB) February 19, 2013

TOKYO, Japan – February 19, 2013 – Japan Bioinformatics, today announced the release of their Simbiot® Time Course Analysis ‘How-To’ Guide.

The increased efficiency and reduced per-read cost of next generation sequencing (NGS) devices has opened new and exciting opportunities for data analysis. Rather than using a small number of samples, sometimes without replicates, researchers can now effectively compare expression profiles of a large number of samples, complete with replicates.

While many effective and easy-to-use algorithms for gene expression analysis have been developed for handling microarray data, the process is not trivial and requires significant bioinformatics and IT expertise. The Simbiot® Time Course Analysis ‘How-To’ provides a step-by-step guide for handling data management and processing tools that can effectively transform the NGS data into a format that can be analyzed using more sophisticated algorithms.

The Simbiot® Time Course Analysis ‘How-To’ Guide uses a set of 12 NGS samples derived from the first 24 hours of Drosophila embryonic development to demonstrate an expression analysis method with peer-reviewed statistical algorithms. This approach offers a standardized analysis pipeline for expression data generated by high-speed sequencing technologies.

Download the complete Simbiot® Time Course Analysis ‘How-To’ Guide here.

About Japan Bioinformatics

Japan Bioinformatics KK is a Tokyo-based biotechnology company specializing in software development, as well as bioinformatics and information technology services to the life science community, including biotechnology, academia, research, pharmaceutical and bio-devices organizations.

They company's main product, Simbiot®, is a system for management and analysis of biological data. The application is available in a single-user, as well as a private server configuration that easily integrates into the client’s environment, including laboratory information management systems (LIMS), as well as custom and proprietary data formats, analytics and annotations. The system combines reliable data management, distribution, collaboration and analysis tools that support commercial and proprietary data formats, with specific focus on next generation sequencing (NGS) data.

In addition to software products, Japan Bioinformatics offers data analysis, bioinformatics and software development services. Learn more at http://www.japanbioinformatics.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10444186.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
2. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
3. Japanese Universities Offered Access to SPIE Digital Library in Collaboration with JUSTICE
4. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
5. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
6. First Baby With Artificial Heart in Japan
7. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
8. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
9. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
10. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
11. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 2016 , ... Clinovo , the cloud-based eClinical software ... Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... San Mateo, California on February 10th and 11th. Watch 2-min video . ...
(Date:2/9/2016)...  DNAtrix, a clinical stage, biotechnology company ... its lead product, DNX-2401, has been designated ... medicinal product for the treatment of glioma. ... approximately 25,000 people a year in the ... --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... LONDON , Feb. 9, 2016 /PRNewswire/ ... (PTP1B) Inhibitors-Pipeline Insights, 2016", report provides in ... their development activities around the Protein-Tyrosine Phosphatase ... the product profiles in various stages of ... Phase II, Phase III and Preregistration. Report ...
(Date:2/8/2016)... N.C. , Feb. 8, 2016 Novan, Inc. today ... Chairman of the Board of Directors of Novan. In addition, ... North Carolina . --> ... Company also announced that it received a total of $32.8 million ... 2015 from its private investor network originating throughout the Research Triangle ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
Breaking Biology News(10 mins):